Abstract

Metabolomics is a new type of omics for identifying and quantifying the small molecule metabolites, and reflects the real-time pathophysiological conditions in the living organisms. Renal disorders have a wide-ranging influences on circulating metabolites since the kidney is a vital organ for metabolite handling. In recent years, metabolomics has increasingly been used in chronic kidney disease research to discover new biomarkers for early diagnosis or prediction of progression, and to explore the kidney disease pathogenesis. Key words: Metabolomics; Chronic kidney disease; Biomarker

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.